The first grant of $5 million from Ohio’s Third Frontier Program will go to the Center for Stem Cell and Regenerative Medicine, and an additional $5 million will be matched through project participants. The center’s members include Case Western Reserve University, Cleveland Clinic, University Hospitals and the local biopharmaceutical company Athersys.

Some of the grant money will go to Athersys to perform a Phase II clinical trial on MultiStem, an adult stem cell therapy to help victims of heart attacks, strokes and a complication of bone marrow transplants.